Launch Neuberg DIGIPATH, Powered by OptraSCAN in UAE, India and South Africa to provide advanced and affordable digital pathology solutions
Neuberg Diagnostics and OptraSCAN, announced launching of Global TELEPath Network for the pathologist community in UAE, India and South Africa under a new joint venture namely, “Neuberg DIGIPATH, Powered by OptraSCAN”. The joint venture is in it’s initial phase and will be formed in three months. The announcement was made at the annual event for the international medical laboratory community, MedLab 2019 in Dubai, United Arab Emirates. The Global TELEPath Network, promoted by OptraSCAN was launched in the US and European region last year.
The joint venture combines histopathology and cytology services provided by Neuberg Diagnostics with digital pathology capabilities offered by OptraSCAN and brings to the table a whole new array of services related to digitisation of tissue slides and telepathology with an objective of making new-age life-saving healthcare technology available to human kind. The JV promises access to a large pool of histopathologists – who diagnose and study diseases using expert medical interpretation of cells and tissue samples – from UAE, India and South Africa.
Dr GSK Velu, Founder and Chairman, Neuberg Diagnostics said “With OptraSCAN’s expertise in providing new-age technology that are well-equipped with AI amd ML based analysis tools, the newly combined organisation will enable us to expand the service as well as the geographic reach of Neuberg’s existing lab services. We expect the economies of scale from this partnership to help us bring better value to our clients and expand our service offerings.” This new venture ‘Neuberg DIGIPATH, Powered by OptraSCAN’ services comprise of digitisation of tissue slides, storage and archiving, slide discussions and digital learning modules, automated slide processing platforms and second-opinion tele-consulting services. Apart from user-friendly features like a compact, high-resolution and cloud-ready platform with smart-recognition facilities, the new entity promises an economically priced “walk-away technology” for the healthcare sector.
“This new venture, ‘Neuberg DIGIPATH, Powered by OptraSCAN’, is the next step forward in a healthcare collaboration that combines the expertise and capabilities of OptraSCAN with Neuberg Diagnostics to provide advanced and affordable digital pathology products in India, Middle East, Africa and beyond. “OptraSCAN’s Global TELEPath Network has great market traction in the USA and European region, so this venture is also a part of our global strategy to create innovative healthcare affiliations with leading healthcare providers around the globe to enhance our reach in untapped regions.” said Abhi Gholap, Founder and CEO, OptraSCAN.
Through this partnership joint venture, both companies aim to expand their market base and have planned a phase and region-wise expansion. In phase-I, the JV intends to launch its products and services in UAE, India and South Africa; followed by Phase-II, wherein it hopes to expand their offerings to rest of Asia, Europe and the rest of Africa. The JV partners intend to make on-demand cutting-edge digital pathology solutions available to leading hospitals in the Middle East region thus taking healthcare and diagnostics deep into the digital age.